1/85
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
order of msk physical exam
1. inspection
2. ROM
3. palpation
4. neurovascular
5. special testing
xray basics rule of two
two views - a/p and lat
two joints - joint above and below
two occasions - repeat scans
two limbs - compare
xray interpretation ABCS
a - adequacy, alignment
b - bones
c - cartilage
s - soft tissues
alignment
anatomic relationship between bones on xray
bones
examine bones for fracture lines or distortions
cartilage
examine the joint spaces on xrays for increased or decreased joint space
soft tissue
swelling and joint effusions
foreign bodies
air (break in integrity)
interpreting fx: direction
transverse - straight across
oblique - angled
spiral - curves around bone
comminuted - 3+ pieces
interpreting fx: description
pattern
displacement
interpreting fx: patterns
segmental - two fx in same bone creating floating segment
impacted - one fragment is driven into another
compression - bone is crushed, often in vertebrae
depression - portion of bone is pushed inward (often in skull fx)
interpreting fx: displacement
nondisplaced
displaced
angulated
rotated
shortened
nondisplaced
bone fragments maintain alignment
displaced
bone fragments are out of alignment - based off most distal segment
angulated
fragments are at an angle to each other
rotated
one fragmented is twisted relative to the other
shortened
overlapping fragments reduce the bone's length
DEXA z-scores
normal -1.0+
penia -1.0-(-2.5)
porosis -2.5+
bisphosphonate examples
alendronate
risedronate
ibandronate
zoledronic (IV)
bisphosphonate moa
bind to hydroxyapatite on bone surfaces -> inhibit osteoclast-mediated bone resorption -> reducing bone turnover
bisphosphonate indications
tx and prev of postmenopausal osteoporosis
tx of osteoporosis in men
tx of glucocorticoid-induced osteoporosis
tx of paget's disease of bone
bisphosphonate z-score improvement
alen, rise, zole all have data that z score is improved in vertebrae and hip/femoral neck
bisphosphonate se
GI - nausea, abd pain, dyspepsia
msk pain
HA
flu-like symp (IV formula)
bisphosphonate adr
osteonecrosis of jaw
atypical femur fx
esophageal ulceration
bisphosphonate labs
serum calcium and vit d
renal fxn
BMD
oral exam at baseline
bisphosphonate drug
calcium supplements and antacids
NSAIDs
PPI
bisphosphonate contraindications
known esophageal stricture
hx of known malabsorption
bisphosphonate special pops
peds - specific conditions only
geri - careful monitoring
preg/lac - nope
renal - dose adjust on crcl
hepatic - ok
bisphosphonate pearls
oral taken on empty stomach with water
remain upright 30 mins after taking
dental exams
drug holiday after 3-5 years of taking
adequate calcium and vit d intake
anti-RANKL antibody example and dose
denosumab (prolia)
60mg SQ q6m
anti-RANKL antibody moa
monoclonal antibody that binds to and inactivated receptor activator of nuclear factor kappa-B ligand -> inhibiting osteoclast formation, maintenance, and survival -> reducing bone resorption and turnover
anti-RANKL antibody indications
postmenopausal osteoporosis
male osteoporosis
steroid induced osteoporosis
cancer tx induced bone loss
bone metastases
hyper ca of malignancy
anti-RANKL antibody se
msk pain
diarrhea
hypertension
hypocalcemia, hyperphosphatemia
URI symptoms
dizziness, vertigo
peripheral edema
dermatitis/eczema/rash
anti-RANKL antibody adr
severe hypocalcemia
anaphylaxis
vasculitis
serious infection
ONJ
atypical femur fractures
vertebral fracture
pancreatitis
anti-RANKL antibody BBW
severe hypocalcemia in advanced CKD (GFR < 30)
anti-RANKL antibody labs
oral exam at baseline
pregnancy test at baseline
serum calcium
vit D levels
consider mag + phosphate levels
DEXA ever 1-2 years
anti-RANKL antibody special pops
peds - specialist
geri - caution
preg/lac - nope
renal - caution in crcl <30
hepatic - ok
anti-RANKL antibody drug
avoid bisphosphonates, anabolics, synthetic PTH agents, calcimimetics
anti-RANKL antibody pearls
do not incorporate into bone matrix
effect is rapidly reversible when d/c
preferred in renal impairment
anabolic osteoporosis examples
teriparatide
abaloparatide
romosozumab
anabolic osteoporosis moa teri and abalo
PTH analogs that stimulate bone formation
anabolic osteoporosis moa romo
sclerostin inhibitor that increases bone formation and decreases bone resorption
anabolic osteoporosis indications
postmenopausal osteoporosis at high risk for fx
increase bone mass in men with osteoporosis at high risk for fx
treatment of glucocorticoid related osteoporosis
anabolic osteoporosis se
injection site reaction
nausea, dizziness, HA
leg cramps
hypercalcemia
arthralgia
anabolic osteoporosis adr
osteosarcoma
hypercalcemia
ortho hypo
anabolic osteoporosis bbw
teri and abalo - risk of osteosarcoma
romo - increased risk of CV death, stroke, and MI
anabolic osteoporosis drug
caution with digoxin
anabolic osteoporosis special pops
peds - nope
geri - ok
preg/lac - nope
hepatic - caution
anabolic osteoporosis renal
teri and abal - caution in severe
romo - no go in severe
anabolic osteoporosis pearls
reserved for pts at very high risk of fx
ensure adequate calcium and vit d intake
no long term data
NSAID examples
ibuprofen
naproxen
celecoxib
diclofenac
meloxicam
NSAID moa
inhibit cox 1 and 2 enzymes reducing prostaglandin synthesis
melox and cele are cox 2 selective
NSAID indications
mild - mod pain management
inflammation
fever reduction
OA
RA
dysmenorrhea
NSAID se
GI upset (dyspepsia, nausea, abd p!)
HA
dizziness
edema
NSAID adr
gi bleed or ulceration
cv events
renal impairment
hepatotoxicity
anaphylaxis
NSAID BBW
increased risk of severe cv thrombotic events (MI/stroke)
increased risk of serious GI events
NSAID labs
CBC
CMP
LFT
BP
PPI
NSAID drug
anticoags
antihypertensives
lithium
methotrexate
ace/arb
low-dose aspirin
NSAID special pops
peds - ibu and naproxen ok
geri - caution
preg - avoid if possible
lac - ok
renal - caution, no <30
hepatic - caution
NSAID pearls
lowest dose shortest time
take with food
glucocorticoid uses in msk/rheum
oral and injectable
if systemic - go oral
if one joint - go inj
oral glucocorticoids
multiple joints
systemic sx present
6-24hr onset
days to weeks duration depending on taper
higher risk of systemic effects
inj glucocorticoids
single or few joints
no systemic sx
takes 24-48 hours
duration weeks to months
minimal systemic effects
tramadol drug class
atypical opioid analgesic
schedule IV controlled
tramadol moa
weak mu-opioid receptor agonist
inhibits reuptake of serotonin and norepi
tramadol indications
mod - mod/severe acute pain
mod - mod/severe chronic pain
mainly short term use due to dependency risk
tramadol se
N/V
constipation
dizziness and vertigo
drowsiness
HA
dry mouth
tramadol adr
seizures
serotonin syndrome
respiratory depression
addiction/dependence
anaphylaxis and hypersensitivity
tramadol BBW
risk of addiction, abuse, misuse
life-threatening resp depression
accidental ingestion, esp in children
neonatal withdrawal syndrome
risk of concomitant use with benzos
cyp interactions
tramadol labs
LFTs
renal fxn
drug screening in chronic pain management
tramadol drug
CYP2D6
CYP3A4
serotonins
benzos
warfarin
tramadol special pops
peds - nope
geri - caution
preg/lac - nope
renal - dose adjust
hepatic - dose adjust
opioid examples
morphine
oxycodone
hydrocodone
oxymorphone
hydromorphone
fentanyl
opioid moa
bind to mu receptors in CNS -> inhibit ascending pain pathways -> alter pain perception and emotional response to pain
morphine miligram equivalents
a standardized unit used to compare the potency of different opioid medications
converts dose of any opioid to an equivalent dose of morphine
higher doses of MME associated with
increased risk of:
overdose
respiratory depression
death
CDC MME prescribing guidelines
>50 caution
>90 avoid or carefully justified
opioid indications
moderate to severe acute pain
cancer-related pain
palliative care
chronic pain
opioid se
constipation
N/V
sedation and drowsiness
dizziness
pruritus
opioid induced hyperalgesia
paradoxical state where chronic opioid exposure increases pain sensitivity rather than reducing it
opioid adr
respiratory depression
addiction and physical dependence
overdose
serotonin syndrome
adrenal insufficiency
opioid BBW
risk of addiction, abuse, and misuse
respiratory depression and death
opioid labs
LFTs
renal function
UDS in chronic management
opioid drug
benzos
CNS depressants
MAOIs
serotonins
opioid special pops
peds - nope
geri - start low titrate slow
preg - nope
lac - low dose short duration ok
opioid renal
morphine - avoid
fentanyl and methadone - preferred in renal impairment
opioid hepatic
dose adjust
start low titrate slow
avoid in severe hepatic impairment
fentanyl preferred